Prices for New US Drugs Rose 35 Percent in 2023 ieyenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ieyenews.com Daily Mail and Mail on Sunday newspapers.
Pharmaceutical companies last year launched new U.S. drugs at prices 35% higher than in 2022, reflecting in part the industry s embrace of expensive therapies for rare diseases like muscular dystrophy, a Reuters analysis found.
Pharmaceutical companies last year launched new U.S. drugs at prices 35% higher than in 2022, reflecting in part the industry's embrace of expensive therapies for rare diseases like muscular dystrophy, a Reuters analysis found. The median annual list price for a new drug was $300,000 in 2023, according to the Reuters analysis of 47 medicines, up from $222,000 a year earlier. In 2021, the median annual price was $180,000 for the 30 drugs first marketed through mid-July, according to a study published in JAMA.
Pharmaceutical companies last year launched new U.S. drugs at prices 35% higher than in 2022, reflecting in part the industry's embrace of expensive therapies for rare.